Buy HUMULIN M 70/30 Online

Overview: HUMULIN M 70/30 is an insulin preparation designed to manage blood glucose levels in patients with diabetes mellitus. It combines insulin isophane, also known as NPH insulin (Neutral Protamine Hagedorn), with regular insulin in a fixed ratio (70% NPH insulin and 30% regular insulin). This combination provides both intermediate-acting and rapid-acting insulin effects, making it suitable for controlling both mealtime and basal insulin requirements.

Key Features:

1. Dual-Action Formula: Contains 70% NPH insulin (intermediate-acting) and 30% regular insulin (rapid-acting), providing comprehensive blood sugar control throughout the day.
2. Convenient Pen Delivery: Packaged in pre-filled pens for easy and accurate dosing, eliminating the need for syringes and vials.
3. Flexibility in Dosing: Allows for personalized adjustment of insulin dosages based on individual patient needs, including meal patterns and metabolic requirements.
4. Manufactured by Lilly: Produced by Lilly, a reputable pharmaceutical company known for its commitment to diabetes care and insulin innovation.

Indications: HUMULIN M 70/30 is indicated for the treatment of diabetes mellitus in adults and children. It is prescribed to control hyperglycemia (high blood sugar) and maintain glycemic levels throughout the day.

Usage Instructions:

• Administered subcutaneously (under the skin) using the pre-filled HUMULIN M 70/30 pen.
• Dosage and administration frequency should be determined by healthcare providers based on individual patient factors such as meal patterns, metabolic needs, and blood glucose monitoring.

Storage and Handling:

• Store refrigerated (2°C to 8°C / 36°F to 46°F) until first use.
• After first use, may be stored at room temperature (below 30°C / 86°F) for up to 31 days.
• Protect from light and excessive heat.

Warnings and Precautions:

• Hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) may occur; patients should be educated on recognizing and managing these conditions.
• Regular monitoring of blood glucose levels is essential to adjust insulin dosage appropriately.
• Use caution in patients with hypokalemia (low potassium levels) or renal impairment.

Adverse Reactions: Common adverse reactions may include injection site reactions, allergic reactions, hypoglycemia, and weight gain. Patients should be advised to report any unusual symptoms promptly.

Conclusion: HUMULIN M 70/30 offers a reliable treatment option for individuals with diabetes, combining intermediate-acting and rapid-acting insulin in a convenient pen format. Manufactured by Lilly, it adheres to high standards of quality and efficacy, contributing to improved glycemic control and enhanced quality of life for patients managing diabetes mellitus.